Growth regulation of human prostate cancer cells by bone morphogenetic protein-2

Cancer Research

Volumn 57, Issue 22, 1997, Pages 5022-5027

  Ide, Hisamitsu ^a,b   Yoshida, Teruhiko ^a   Matsumoto, Nobuyuki ^a   Aoki, Kazunori ^a   Osada, Yukio ^b   Sugimura, Takashi ^a   Terada, Masaaki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; GROWTH REGULATION; HUMAN; HUMAN CELL; MALE; OSSIFICATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MORPHOGENETIC PROTEINS; CELL DIVISION; HUMANS; MALE; METRIBOLONE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, GROWTH FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; TESTOSTERONE CONGENERS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030716244     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Clarke, N. W., McClure, J., and George, N. J. Morphometric evidence for bone resorption and replacement in prostate cancer. Br. J. Urol., 68: 74-80, 1991.
2. Scher, H. I., and Yagoda, A. Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. Am. J. Med., 82: 6-28, 1987.
3. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet, 1: 571-573, 1889.
4. Hart, I. R., and Saini, A. Biology of tumour metastasis [see comments]. Lancet, 339: 1453-1457, 1992.
5. Orr, F. W., Sanchez-Sweatman, O. H., Kostenuik, P., and Singh, G. Tumor-bone interactions in skeletal metastasis. Clin. Orthop., 312: 19-33, 1995.
6. Koutsilieris, M. Osteoblastic metastasis in advanced prostate cancer. Anticancer Res., 13: 443-449, 1993.
7. Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., and Wang, E. A. Novel regulators of bone formation: molecular clones and activities. Science (Washington DC), 242: 1528-1534, 1988.
8. Wozney, J. M. The bone morphogenelic protein family and osteogenesis. Mol. Reprod. Dev., 32: 160-167, 1992.
9. Vukicevic, S., Luyten, F. P., and Reddi, A. H. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc. Natl. Acad. Sci. USA, 86: 8793-8797, 1989.
10. Reddi, A. H. Bone and cartilage differentiation. Curr. Opin. Genet. Dev., 4: 737-744, 1994.
11. Yamaguchi, A., Ishizuya, T., Kintou, N., Wada, Y., Katagiri, T., Wozney, J. M., Rosen, V., and Yoshiki, S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem. Biophys. Res. Commun., 220: 366-371, 1996.
12. Hogan, B. L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes. Dev., 10: 1580-1594, 1996.
13. Cunningham, N. S., Paralkar, V., and Reddi, A. H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc. Natl. Acad. Sci. USA, 89: 11740-11744, 1992.
14. Lind, M., Eriksen, E. F., and Bunger, C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone, 18: 53-57, 1996.
15. Paralkar, V. M., Weeks, B. S., Yu, Y. M., Kleinman, H. K., and Reddi, A. H. Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen. J. Cell. Biol., 119: 1721-1728, 1992.
16. ten Dijke, P., Ichijo, H., Franzen, P., Schulz, P., Saras, J., Toyoshima, H., Heldin, C. H., and Miyazono, K. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene, 8: 2879-2887, 1993.
17. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C. H. Characterization of type I receptors for transforming growth factor-beta and activin. Science (Washington DC), 264: 101-104, 1994.
18. Liu, F., Ventura, F., Doody, J., and Massagué, J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol., 15: 3479-3486, 1995.
19. Nohno, T., Ishikawa, T., Saito, T., Hosokawa, K., Noji, S., Wolsing, D. H., and Rosenbaum, J. S. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J. Biol. Chem., 270: 22522-22526, 1995.
20. Rosenzweig, B. L., Imamura, T., Okadome, T., Cox, G. N., Yamashita, H., ten Dijke, P., Heldin, C. H., and Miyazono, K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA, 92: 7632-7636, 1995.
21. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., and Miyazono, K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem., 269: 16985-16988, 1994.
22. Koenig, B. B., Cook, J. S., Wolsing, D. H., Ting, J., Tiesman, J. P., Correa, P. E., Olson, C. A., Pecquet, A. L., Ventura, F., Grant, R. A., et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell. Biol., 14: 5961-5974, 1994.
23. Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J. Biol. Chem., 271: 21345-21352, 1996.
24. Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., Andries, M., Smith, J. C., Heldin, C. H., and Miyazono, K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell. Biol., 130: 217-226, 1995.
25. Ide, H., Katoh, M., Sasaki, H., Yoshida, T., Aoki, K., Nawa, Y., Osada, Y., Sugimura, T., and Terada, M. Cloning of human bone morphogenetic protein receptor type IB (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs. Oncogene, 14: 1377-1382, 1997.
26. Bentley, H., Hamdy, F. C., Hart, K. A., Seid, J. M., Williams, J. L., Johnstone, D., and Russell, R. G. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer, 66: 1159-1163, 1992.
27. Harris, S. E., Harris, M. A., Mahy, P., Wozney, J., Feng, J. Q., and Mundy, G. R. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate, 24: 204-211, 1994.
28. Tilley, W. D., Wilson, C. M., Marcelli, M., and McPhaul, M. J. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res., 50: 5382-5386, 1990.
29. Lundwall, A. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem. Biophys. Res. Commun., 161: 1151-1159, 1989.
30. Nakajima-Iijima, S., Hamada, H., Reddy, P., and Kakunaga, T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA, 82: 6133-6137, 1985.
31. Ozaki, K., Yoshida, T., Ide, H., Saito, I., Ikeda, Y., Sugimura, T., and Terada, M. Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC. Hum. Gene Ther., 7: 1483-1490, 1996.
32. Kokontis, J., Takakura, K., Hay, N., and Liao, S. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res., 54: 1566-1573, 1994.
33. Young, C. Y., Montgomery, B. T., Andrews, P. E., Qui, S. D., Bilhartz, D. L., and Tindall, D. J. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51: 3748-3752, 1991.
34. Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C., Trapman, J., Brinkmann, A. O., and Mulder, E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun., 173: 534-540, 1990.
35. Kokontis, J., Ito, K., Hiipakka, R. A., and Liao, S. Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone and antihormone specificity in gene transactivation. Receptor, 1: 271-279, 1991.
36. McCarthy, S. A., and Bicknell, R. Inhibition of vascular endothelial cell growth by activin-A. J. Biol. Chem., 268: 23066-23071, 1993.
37. Wallen, J. W., Cate, R. L., Kiefer, D. M., Riemen, M. W., Martinez, D., Hoffman, R. M., Donahoe, P. K., Von Hoff, D. D., Pepinsky, B., and Oliff, A. Minimal antiproliferative effect of recombinant Müllerian inhibiting substance on gynecological tumor cell lines and tumor explants. Cancer Res., 49: 2005-2011, 1989.
38. Matzuk, M. M., Finegold, M. J., Su, J. G., Hsueh, A. J., and Bradley, A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (Lond.), 360: 313-319, 1992.
39. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., and Sporn, M. B. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA, 82: 119-123, 1985.
40. Goodman, L. V., and Majack, R. A. Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. J. Biol. Chem., 264: 5241-5244, 1989.
41. Vivien, D., Redini, F., Galera, P., Lebrun, E., Loyau, G., and Pujol, J. P. Rabbit articular chondrocytes (RAC) express distinct transforming growth factor-beta receptor phenotypes as a function of cell cycle phases. Exp. Cell Res., 205: 165-170, 1993.
42. Myoken, Y., Kan, M., Sato, G. H., McKeehan, W. L., and Sato, J. D. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. Exp. Cell Res., 191: 299-304, 1990.
43. Zhao, Y., and Young, S. L. Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth inhibition. J. Biol. Chem., 271: 2369-2372, 1996.
44. Aono, A., Hazama, M., Notoya, K., Taketomi, S., Yamasaki, H., Tsukuda, R., Sasaki, S., and Fujisawa, Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem. Biophys. Res. Commun., 210: 670-677, 1995.
45. Liu, X. H., Wiley, H. S., and Meikle, A. W. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor. J. Clin. Endocrinol. Metab., 77: 1472-1478, 1993.
46. Steiner, M. S. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol., 153: 1085-1096, 1995.
47. Fiorelli, G., De Bellis, A., Longo, A., Giannini, S., Natali, A., Costantini, A., Vannelli, G. B., and Serio, M. Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J. Clin. Endocrinol. Metab., 72: 740-746, 1991.
48. Koivisto, P., Kononen, J., Palmberg, C., Tammela, T., Hyytinen, E., Isola, J., Trapman, J., Cleutjens, K., Noordzij, A., Visakorpi, T., and Kallioniemi, O. P. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res., 57: 314-319, 1997.
49. Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinanen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., and Kallioniemi, O. P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet., 9: 401-406, 1995.
50. Gaddipati, J. P., McLeod, D. G., Heidenberg, H. B., Sesterhenn, I. A., Finger, M. J., Moul, J. W., and Srivastava, S. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res., 54: 2861-2864, 1994.
51. Taplin, M. E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., and Balk, S. P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med, 332: 1393-1398, 1995.